冠状动脉介入治疗中支架血栓形成的防治
《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]
- 期数:
- 2011年第2期
- 页码:
- 270-273
- 栏目:
- 综述
- 出版日期:
- 2010-12-10
文章信息/Info
- Title:
- -
- Author(s):
- -
- Keywords:
- -
- 分类号:
- R543.31
- DOI:
- -
- 文献标识码:
- A
- 摘要:
- 冠状动脉支架介入治疗的水平发展很快，但支架血栓形成仍是临床尚未能最终解决的问题。本文就目前冠状动脉支架血栓的新概念、发生率、发生机制和防治的研究进展作一综述。
- Abstract:
- -
参考文献/References
[1]乔志卿，何奔. 药物洗脱支架植入后的支架内再狭窄的研究进展［J］. 心脏杂志, 2008, 20(3):366-369.
[2]Cutlip DE, Windecker S, Mehran R, et al. On behalf of the Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions［J］. Circulation, 2007, 115(17):2344-2351.
[3]刘普,马依彤. 支架内血栓形成的原因及防治［J］. 心脏杂志, 2008, 20(1):108-110.
[4]Doyle B, Rihal CS, OSullivan CJ, et al. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents［J］. Circulation, 2007, 116(21):2391-2398.
[5]Park DW, Park SW, Lee SW, et al. Frequency of coronary arterial late angiographic stent thrombosis (LAST) in the first six months: outcomes with drug-eluting stents versus bare metal stents［J］. Am J Cardiol, 2007, 99(6):774-778.
[6]Stone GW, Moses JW, Ellis SG. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents［J］. N Engl J Med, 2007, 356(10):998-1008.
[7]陈纪林，杨跃进，黄静涵，等. 冠心病真实世界中药物洗脱支架置入术后血栓形成的发生率［J］. 中华心血管病杂志, 2007, 35(12):1133-1135.
[8]Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk［J］. J Am Coll Cardiol, 2006, 48(1):193-202.
[9]Lüscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications［J］. Circulation, 2007, 115(8):1051-1058.
[10]Park DW, Park SW, Park KH, et al. Frequency of and risk factors for stent thrombosis after drug eluting stent implantation during long-term follow-up［J］. Am J Cardiol, 2006, 98(3):352-356.
[11]Philpott AC, Southern DA, Clement FM, et al. Long-term outcomes of patients receiving drug-eluting stents［J］. CMAJ, 2009, 180(2):167-174.
[12]Roy P, Torguson R, Okabe T, et al. Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug eluting stents［J］. J Interv Cardiol, 2007, 20(5):307-313.
[13]中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 经皮冠状动脉介入治疗指南(2009)［J］. 中华心血管病杂志, 2009, 37(1):1-25.
[14]Hirsh J, Guyatt G, Albers GW, et al. Antithrombotic and thrombolytic therapy:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)［J］. Chest, 2008, 134(2):473.
[15]Mehta SR, Bassand JP, Chrolavicius S, et al. Design and rationale of CURRENT-OASIS 7: a randomized, 2 x 2 factorial trial evaluating optimal dosing strategies for clopidogrel and aspirin in patients with ST and non-ST-elevation acute coronary syndromes managed with an early invasive strategy［J］. Am Heart J, 2008, 156(6):1080-1088..
[16]O’Donoghue M, Antman EM, Braunwald E, et al. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis［J］. J Am Coll Cardiol, 2009, 54(8):678-685.
[17]Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes［J］. N Engl J Med, 2009, 361(11):1045-1057.
[18]张孝忠. 新型冠状动脉支架——氮氧化钛生物有效性支架［J］. 心脏杂志, 2008, 20(6):780-782.
备注/Memo
- 备注/Memo:
- 收稿日期：2010-01-18.通讯作者：袁晋青，主任医师，主要从事冠心病介入治疗研究 Email：jqyuan29007@sina.com 作者简介：唐晓芳，硕士生Email：tangxiao.xiaotang@yahoo.com.cn
常用功能
统计/Statistics
- 摘要浏览/Viewed1089
- 评论/Comments
